Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Revenue

Bide Pharmatech had revenue of 368.43M CNY in the quarter ending September 30, 2026, with 4.79% growth. This brings the company's total for the last twelve months to 1.40B, up 9.94% year-over-year. In the year 2025, Bide Pharmatech had annual revenue of 1.32B with 20.13% growth. That makes Bide Pharmatech the 17,175th largest company in the world by revenue and 3,132nd in China.

• Revenue (ttm): 1.40B
• Revenue Growth: +9.94%
• P/S Ratio: 4.15
• Revenue / Employee: 1.90M
• Employees: 734
• Market Cap: 5.50B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Overseas 759.27M 57.4%
• China 564.53M 42.6%

Fiscal year ended Dec 31, 2025 See the full Bide Pharmatech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.32B	221.80M	20.13%
Dec 31, 2024	1.10B	10.15M	0.93%
Dec 31, 2023	1.09B	258.03M	30.94%
Dec 31, 2022	833.83M	227.61M	37.55%
Dec 31, 2021	606.22M	214.75M	54.86%

Data Source: S&P Global Market Intelligence Last updated: Oct 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error